Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Protalix BioTherapeutics, Inc.
HOLD Alapkezelo Zrt. has filed a SCHEDULE 13G to report its beneficial ownership in Protalix BioTherapeutics, Inc. This filing serves as an official disclosure of the investor's equity position.…more
Protalix BioTherapeutics, Inc.
Dr. Aharon Schwartz, a director of Protalix BioTherapeutics, has executed a power of attorney for the filing of SEC forms 3, 4, and 5. This document appoints Dror Bashan, Gilad Mamlok, and Joseph R. Magnas as attorneys-in-fact to handle securities-related filings on his behalf.…more
Protalix BioTherapeutics, Inc.
Yaron Naos of Protalix BioTherapeutics has filed a Power of Attorney, authorizing Dror Bashan, Gilad Mamlok, and Joseph R. Magnas to execute and file Forms 3, 4, and 5 on his behalf in accordance with Section 16 of the Securities Exchange Act. This is an administrative filing to delegate the reporting of securities holdings and transactions.…more
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Pluxee Releases Global Study on Employee Engagement in the Era of AI
Pluxee published a global study of 11,000 employees across 14 countries, identifying three key paradoxes regarding workplace engagement amid inflation and AI. The findings suggest that while employees are prioritizing work-life balance, they remain connected to their organizations and view AI as a positive tool for professional growth.…more
●●●●●●●● ●●●●● ●●●●●●
플럭시가 2026년 상반기 유동성 계약에 따른 자사주 거래 내역을 공시했습니다. 해당 보고서는 시장 유동성 공급을 위한 정기적인 공시로 주가에 미치는 직접적인 영향은 제한적입니다.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.